Calidi Biotherapeutics, Inc. 10-K filing
Filed 2026-03-27 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001493152-26-013242
- Form type
- 10-K
- CIK
- 0001855485
- Primary document
- https://www.sec.gov/Archives/edgar/data/1855485/000149315226013242/form10-k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Calidi Biotherapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-20.2M | - | - |
| Net Income | $-19.9M | - | - |
| Eps Basic | -5.95 | - | - |
| Eps Diluted | -5.95 | - | - |
| Total Assets | $8.9M | - | - |
| Total Liabilities | $5.1M | - | - |
| Shareholders Equity | $3.8M | - | - |
| Operating Cash Flow | $-21.3M | - | - |